Nicotine-containing aggregates and methods for forming same

JP2024513468A5Inactive Publication Date: 2024-11-22ALTRIA CLIENT SERVICES LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023561640
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-04-06
Filing Date
2021-11-24
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing methods for preparing nicotine-containing aggregates for oral products face challenges in achieving uniform particle size and composition, which affect the consistency and efficacy of nicotine delivery.

Method used

A method involving fluidized bed granulation technology is used to prepare nicotine-containing aggregates by feeding solid particulates comprising nicotine-containing powder and a binder solution, with controlled temperature and spray positions, to form aggregates with uniform size and desired properties.

Benefits of technology

The method produces nicotine-containing aggregates with uniform particle sizes ranging from 50 μm to 3,000 μm, enhancing the consistency and effectiveness of nicotine delivery in oral products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The method of preparing a nicotine-containing aggregate includes feeding solid particulates to a fluid bed granulator and feeding a binder solution to the fluid bed granulator such that the binder solution contacts the solid particulates. The solid particulates and / or the binder solution may be fed partially, simultaneously or sequentially to the fluid bed granulator. The binder solution comprises a binder material and a solvent, which may comprise water. Feeding the binder solution to the fluid bed granulator may include spraying the binder solution into the fluid bed of the fluid bed granulator during circulation of the material, such as the solid particulates, therein. The fluid bed may further comprise a filler and / or additive. The filler and / or additive may be fed to the fluid bed granulator before, simultaneously or after the addition of the solid particulates and / or the binder solution.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to nicotine-containing aggregates suitable for use with or in oral products, and methods for preparing same. [Background technology]

[0002] Oral nicotine products are available in a variety of forms, including chewing gum, sprays, lozenges, dissolving tablets, non-dissolving chewing gum, films, gels, capsules, sticks (e.g., coated wooden dowels and exotic dissolving sticks), and pouches (e.g., containing fiber or granules). Oral products may have nicotine strengths that provide a familiar experience for adult tobacco consumers. Summary of the Invention [Problem to be solved by the invention]

[0003] At least some exemplary embodiments relate to methods for preparing nicotine-containing aggregates. [Means for solving the problem]

[0004] In at least one exemplary embodiment, a method of preparing a nicotine-containing agglomerate includes: feeding solid particulates to a fluid bed granulator, the solid particulates comprising a nicotine-containing powder; and feeding a binder solution to the fluid bed granulator, such that the binder solution contacts the solid particulates.

[0005] In at least one exemplary embodiment, the binder solution and the solid particulates can be fed simultaneously into the fluid bed granulator.

[0006] In at least one exemplary embodiment, the binder solution includes a binder material, which may include a pyrrolidone polymer, a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate, a copolymer of methacrylate and acrylic acid, hydroxypropyl methylcellulose (HPMC), or any combination thereof.

[0007] In at least one exemplary embodiment, the binder solution includes a binder material and a solvent. The solvent may include water.

[0008] In at least one exemplary embodiment, the binder solution may be dispensed downward from an upper spray location, upward from a lower spray location, sideways from a sideways spray location, or any combination thereof.

[0009] In at least one exemplary embodiment, the method may further comprise circulating the solid particulates within the fluidized bed granulator, and supplying the binder solution to the fluidized bed granulator during circulation of the solid particulates.

[0010] In at least one exemplary embodiment, feeding the solid particulates to the fluid bed granulator may include adding a first portion of the solid particulates to the fluid bed granulator and adding a second portion of the solid particulates to the fluid bed granulator during circulation of the first portion of the solid particulates and during feeding of the binder solution.

[0011] In at least one exemplary embodiment, the second portion of the solid particulates can be sprayed onto other materials inside the fluid bed granulator.

[0012] In at least one exemplary embodiment, the binder solution can have a binder inlet temperature ranging from 1°C to 99°C and the solid particulate can have a solid particulate inlet temperature ranging from 1°C to 100°C.

[0013] In at least one exemplary embodiment, the nicotine-containing powder may include a plurality of particulates having an average diameter ranging from 0.1 μm to 3 mm.

[0014] In at least one exemplary embodiment, the method may further comprise subjecting the solid particulate to a pretreatment prior to providing the solid particulate.

[0015] In at least one exemplary embodiment, the pre-treating may include spraying the nicotine-containing powder with a binder material to pre-wet the solid particulates.

[0016] In at least one exemplary embodiment, the pre-treating can include pre-mixing the solid particulates.

[0017] In at least one exemplary embodiment, the solid particulate may further comprise a filler material.

[0018] In at least one exemplary embodiment, the method may further comprise contacting the filler material with the nicotine-containing powder.

[0019] In at least one exemplary embodiment, the filler may include a polysaccharide, a bulk sweetener, a sugar alcohol, or any combination thereof.

[0020] In at least one exemplary embodiment, the method may further comprise adding a filler to the fluid bed granulator, wherein the filler contacts the solid particulates.

[0021] In at least one exemplary embodiment, feeding the solid particulates to the fluid bed granulator can include spraying the solid particulates onto the filler material.

[0022] In at least one exemplary embodiment, the solid particulate may further comprise a flavoring, a pH adjuster, an antioxidant, or any combination thereof.

[0023] In at least one exemplary embodiment, the method can further include adding an additive to the fluid bed granulator, wherein the additive contacts the solid particulates, the additive comprising a flavoring, a pH adjuster, an antioxidant, or any combination thereof. [Brief description of the drawings]

[0024] Various features and advantages of the non-limiting embodiments herein will become more apparent from a consideration of the detailed description in conjunction with the accompanying drawings, which are provided for illustrative purposes only and should not be construed as limiting the scope of the claims. The accompanying drawings are not to be considered as drawn to scale unless explicitly noted. For clarity, various dimensions of the drawings may be exaggerated.

[0025] [Figure 1] FIG. 1 is a flow diagram illustrating a method for preparing a nicotine-containing aggregate according to at least one exemplary embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0026] Several detailed exemplary embodiments are disclosed herein. However, the specific structural and functional details disclosed herein are merely representative for purposes of describing the exemplary embodiments. However, the exemplary embodiments may be embodied in many alternative forms and should not be construed as being limited to only the exemplary embodiments described herein.

[0027] Thus, while exemplary embodiments are susceptible to various modifications and alternative forms, exemplary embodiments thereof have been shown by way of example in the drawings and will be described in detail herein. It is to be understood, however, that there is no intention to limit the exemplary embodiments to the particular forms disclosed, but on the contrary, the exemplary embodiments encompass all modifications, equivalents, and alternatives falling within the scope of the exemplary embodiments. Like numbers refer to like elements throughout the description of the figures.

[0028] When an element or layer is referred to as being "on," "connected to," "coupled to," or "covering" another element or layer, it should be understood that it can be directly connected to, coupled to, or covering the other element or layer, or that intervening elements or layers may be present. In contrast, when an element is referred to as being "directly on," "directly connected to," or "directly coupled to" another element or layer, there are no intervening elements or layers. As used herein, like numbers refer to like elements. As used herein, the term "and / or" includes any and all combinations or subcombinations of one or more of the associated listed items.

[0029] In this specification, terms such as first, second, third, etc. may be used to describe various elements, regions, layers, and / or sections, but it should be understood that these elements, regions, layers, and / or sections should not be limited by these terms. These terms are used only to distinguish one element, region, layer, or section from another region, layer, or section. Thus, a first element, component, region, layer, or section described below can be referred to as a second element, region, layer, or section without departing from the teachings of the exemplary embodiments.

[0030] For ease of description, spatially relative terms (e.g., "beneath," "below," "lower," "above," "upper," "inside," "outside," etc.) may be used herein to describe the relationship of one element or feature to another element or feature as depicted in the figures. It should be understood that the spatially relative terms are intended to encompass different orientations of the device during use and operation in addition to the orientation depicted in the figures. For example, if the device in the figures were turned over, elements described as "below" or "beneath" other elements or features would be oriented "above" the other elements or features. Thus, the term "below" may encompass both an orientation above and below. Also, the device may be otherwise oriented (rotated 90 degrees, oriented in other directions), and the spatially relative descriptors used herein would be interpreted accordingly.

[0031] The terms used herein are for the purpose of describing various exemplary embodiments only and are not intended to be limiting of the exemplary embodiments. As used herein, the singular forms "a," "an," and "the" are intended to include the plural forms unless the context clearly indicates otherwise. It will be further understood that the terms "includes," "including," "comprises," and / or "comprising" specify the presence of stated features, integers, steps, operations, and / or elements, but do not exclude the presence or addition of one or more other features, integers, steps, operations, elements, and / or groups thereof.

[0032] Exemplary embodiments are described herein with reference to cross-sectional views, which are schematic illustrations of exemplary embodiments. As such, variations from the illustrated forms are expected. Thus, exemplary embodiments should not be construed as being limited to the forms of regions illustrated herein, but are intended to include deviations and variations in form. When the term "about" or "substantially" is used in connection with a numerical value, the associated numerical value is intended to include a tolerance of ±10% around the stated numerical value, unless the context indicates otherwise.

[0033] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by those skilled in the art to which the exemplary embodiments belong. Furthermore, terms, including those defined in commonly used dictionaries, should be interpreted as having a meaning consistent with the meaning in the context of the relevant technology, and will not be interpreted in an idealized or overly formal sense unless expressly defined in this specification.

[0034] At least one exemplary embodiment relates to a method for forming a nicotine-containing aggregate suitable for inclusion in an oral product. In some exemplary embodiments, the nicotine-containing aggregate can be prepared using a fluidized bed granulator technique. The nicotine-containing aggregate prepared using such a technique can be substantially uniform, such that the nicotine-containing aggregate has a mean particle size (90% distribution) ranging from about 50 μm to about 3,000 μm (e.g., from about 100 μm to about 2,000 μm, or from about 500 μm to about 1,000 μm). For example, the nicotine-containing aggregates may be about 50 μm or more (e.g., about 100 μm or more, about 200 μm or more, about 300 μm or more, about 400 μm or more, about 500 μm or more, about 600 μm or more, about 700 μm or more, about 800 μm or more, about 900 μm or more, about 1,000 μm or more, about 1,100 μm or more, about 1,200 μm or more, about 1,300 μm or more, about 1,400 μm or more, about 1,500 μm or more, about The average particle size (90% distribution) may be 1,600 μm or more, about 1,700 μm or more, about 1,800 μm or more, about 1,900 μm or more, about 2,000 μm or more, about 2,100 μm or more, about 2,200 μm or more, about 2,300 μm or more, about 2,400 μm or more, about 2,500 μm or more, about 2,600 μm or more, about 2,700 μm or more, about 2,800 μm or more, or about 2,900 μm or more. The nicotine-containing aggregates may be about 3,000 μm or less (e.g., about 2,900 μm or less, about 2,800 μm or less, about 2,700 μm or less, about 2,600 μm or less, about 2,500 μm or less, about 2,400 μm or less, about 2,300 μm or less, about 2,200 μm or less, about 2,100 μm or less, about 2,000 μm or less, about 1,900 μm or less, about 1,800 μm or less, about 1,700 μm or less, about 1,600 μm or less, about 1,800 μm or less, about 1,900 μm or less, about 2,100 μm or less, about 2,200 μm or less, about 2,300 μm or less, about 2,400 μm or less, about 2,500 μm or less, about 2,600 μm or less, about 2,700 μm or less, about 2,800 μm or less, about 2,900 μm or less, about 30 ... The average particle size (90% distribution) may be about 0 μm or less, about 1,500 μm or less, about 1,400 μm or less, about 1,300 μm or less, about 1,200 μm or less, about 1,100 μm or less, about 1,000 μm or less, about 900 μm or less, about 800 μm or less, about 700 μm or less, about 600 μm or less, about 500 μm or less, about 400 μm or less, about 300 μm or less, about 200 μm or less, or about 100 μm or less.

[0035] In at least one exemplary embodiment, the nicotine-containing aggregate may have a moisture content of about 15% or less (e.g., about 14% or less, about 13% or less, about 12% or less, about 11% or less, about 10% or less, about 9% or less, about 8% or less, about 7% or less, about 6% or less, about 5% or less, about 4% or less, about 3% or less, about 2% or less, or about 1% or less).

[0036] In at least one exemplary embodiment, the nicotine-containing aggregates are about 25 wt.% or less (e.g., about 24 wt.% or less, about 23 wt.% or less, about 22 wt.% or less, about 21 wt.% or less, about 20 wt.% or less, about 19 wt.% or less, about 18 wt.% or less, about 17 wt.% or less, about 16 wt.% or less, about 15 wt.% or less, about 14 wt.% or less). % or less, about 13 wt.% or less. wt.% or less, about 12 wt.% or less, about 11 wt.% or less, about 10 wt.% or less, about 9 wt.% or less, about 8 wt.% or less, about 7 wt.% or less, about 6 wt.% or less, about 5 wt.% or less, about 4 wt.% or less, about 3 wt.% or less, about 2 wt.% or less, or about 1 wt.% or less).

[0037] In at least one exemplary embodiment, the nicotine-containing aggregate can include a plurality of particulate aggregates or clusters. In at least one exemplary embodiment, the nicotine-containing aggregate can include a plurality of nicotine particles as liquid or solid droplets or particles. In at least one exemplary embodiment, each nicotine-containing aggregate can include an amount of nicotine particles ranging from about 0.1 wt.% to about 40 wt.%. For example, the nicotine-containing aggregate can include about 0.1 wt.% or more (e.g., about 0.5 wt.% or more, about 1 wt.% or more, about 5 wt.% or more, about 10 wt.% or more, about 15 wt.% or more, about 20 wt.% or more, about 25 wt.% or more, about 30 wt.% or more, or about 35 wt.% or more) of nicotine particles. The nicotine-containing aggregate can contain about 40 wt.% or less (e.g., about 35 wt.% or less, about 30 wt.% or less, about 25 wt.% or less, about 20 wt.% or less, about 15 wt.% or less, about 10 wt.% or less, about 5 wt.% or less, about 1 wt.% or less, or about 0.5 wt.% or less) nicotine particles.

[0038] In at least one exemplary embodiment, the nicotine particles may have an average particle size (90% distribution) ranging from about 0.1 μm to about 3 mm. For example, the nicotine particles may have an average particle size (90% distribution) of about 0.1 μm or more (e.g., about 0.2 μm or more, about 0.5 μm or more, about 1 μm or more, about 1.5 μm or more, about 2 μm or more, or about 2.5 μm or more). The nicotine particles may have an average particle size of about 3 mm or less (e.g., about 2.9 mm or less, about 2.8 mm or less, about 2.5 mm or less, about 2 mm or less, about 1.5 μm or less, about 1 μm or less, about 0.5 μm or less, or about 0.2 μm or less).

[0039] In at least one exemplary embodiment, the nicotine particles include nicotine, a nicotine complex (such as nicotine polacrilex), a nicotine salt, or any combination thereof. The nicotine salt may include, for example, citrate, monotartrate, bitartrate, tartrate dihydrate, salicylate, sulfate, bisulfate, phosphate, acid phosphate, acetate, lactate, succinate, maleate, fumarate, gluconate, saccharate, benzoate, methanesulfonate, hydrochloride, hydrobromide, hydroiodide, or a combination thereof.

[0040] In at least one exemplary embodiment, the nicotine-containing aggregates can include a binder material. For example, each nicotine-containing aggregate can include about 40 wt.% or less (e.g., about 35 wt.% or less, about 30 wt.% or less, about 25 wt.% or less, about 20 wt.% or less, about 15 wt.% or less, about 10 wt. or less, about 5 wt.% or less, about 4 wt.% or less, about 3 wt.% or less, about 2 wt.% or less, or about 1 wt.% or less) of a binder material. In at least one exemplary embodiment, the binder material includes a pyrrolidone polymer, a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate, a copolymer of methacrylic acid and acrylic acid, hydroxypropyl methylcellulose (HPMC), or any combination thereof.

[0041] In at least one exemplary embodiment, the nicotine-containing aggregates can include a filler. For example, each nicotine-containing aggregate can include about 99 wt.% or less (e.g., about 95 wt.% or less, about 90 wt.% or less, about 85 wt.% or less, about 80 wt.% or less, about 75 wt.% or less, about 70 wt.% or less, about 65 wt.% or less, about 60 wt.% or less, about 55 wt.% or less, about 50 wt.% or less, about 45 wt.% or less, about 40 wt.% or less, about 35 wt.% or less, about 30 wt.% or less, about 25 wt.% or less, about 20 wt.% or less, about 15 wt.% or less, about 10 wt.% or less, about 5 wt.% or less, or about 1 wt.% or less) of a filler.

[0042] In at least one exemplary embodiment, the filler comprises a polysaccharide, a bulk sweetener, a sugar alcohol, or any combination thereof. The polysaccharide may comprise microcrystalline cellulose, methylcellulose, hydroxypropyl cellulose, hydroxymethylpropyl cellulose, pectin, carboxymethyl cellulose, dextrin, maltodextrin, xanthan gum, agar, carrageenan, guar gum, alginic acid, or any combination thereof. The bulk sweetener may comprise sucrose, glucose, fructose, lactose, phafenose, trehalose, maltose, maltodextrin, or any combination thereof. The sugar alcohol may comprise sorbitol, mannitol, xylitol, maltitol, lactitol, isomalt, or any combination thereof.

[0043] In at least one exemplary embodiment, the nicotine-containing aggregates can include an additive. For example, each nicotine-containing aggregate can include an amount of additive ranging from about 0.1 wt.% to about 40 wt.%. For example, each nicotine-containing aggregate can include about 0.1 wt.% or more (e.g., about 0.5 wt.% or more, about 1 wt.% or more, about 5 wt.% or more, about 10 wt.% or more, about 15 wt.% or more, about 20 wt.% or more, about 25 wt.% or more, about 30 wt.% or more, or about 35 wt.% or more) of additive. Each nicotine-containing aggregate may contain about 40 wt.% or less (e.g., about 35 wt.% or less, about 30 wt.% or less, about 25 wt.% or less, about 20 wt.% or less, about 15 wt.% or less, about 10 wt.% or less, about 5 wt.% or less, or about 1 wt.% or less) of additive.

[0044] In at least one exemplary embodiment, the additive comprises a flavoring, a pH adjuster or regulator, an antioxidant, or any combination thereof.

[0045] In at least one exemplary embodiment, each nicotine-containing aggregate can include an amount of flavoring ranging from 0 wt.% to about 30 wt.%. For example, each nicotine-containing aggregate can include about 0 wt.% or more flavoring (e.g., about 0.1 wt.% or more, about 0.5 wt.% or more, about 1 wt.% or more, about 5 wt.% or more, about 10 wt.% or more, about 15 wt.% or more, about 20 wt.% or more, or about 25 wt.% or more). Each nicotine-containing aggregate can include about 30 wt.% or less flavoring (e.g., about 25 wt.% or less, about 20 wt.% or less, about 15 wt.% or less, about 10 wt.% or less, about 5 wt.% or less, about 1 wt.% or less, or about 0.5 wt.% or less).

[0046] In at least one exemplary embodiment, the flavoring is selected from the group consisting of peppermint, spearmint, wintergreen, menthol, cinnamon, chocolate, vanillin, licorice, clove, anise, sandalwood, geranium, rose oil, vanilla, lemon oil, cassia, fennel, ginger, ethyl acetate, isoamyl acetate, propyl isobutyrate, isobutyl butyrate, ethyl butyrate, ethyl valerate, benzyl formate, limonene, cymene, pinene, linalool, geraniol, citronellol, citral, orange oil, coriander oil, borneol, fruit extracts, coffee, tea, cocoa, mint, pomegranate, acai, raspberry, blueberry, strawberry, boysenberry, cranberry, bourbon, scotch, whiskey, cognac, hydrangea, lavender, apple, peach, pear, cherry, plum, The flavors may include orange, lime, lychee, grape, grapefruit, butter, rum, coconut, almond, pecan, walnut, hazelnut, French vanilla, macadamia, sugar cane, maple, blackcurrant, caramel, banana, malt, espresso, Kahlua, white chocolate, spice flavors such as cinnamon, clove, coriander, basil, oregano, garlic, mustard, nutmeg, rosemary, thyme, tarragon, dill, sage, anise, and fennel, methyl salicylate, linalool, jasmine, coffee, olive oil, sesame oil, sunflower oil, bergamot oil, geranium oil, lemon oil, ginger oil, balsamic vinegar, rice vinegar, and red wine vinegar, allspice, pimento, mango, soursop, sweetsop, eggplant berry, sorrel, or any combination thereof. In at least one exemplary embodiment, the flavoring may be an encapsulated flavoring.

[0047] In at least one exemplary embodiment, each nicotine-containing aggregate can include an amount of pH adjuster ranging from 0 wt.% to about 10 wt.%. For example, each nicotine-containing aggregate can include about 0 wt.% or more (e.g., about 0.1 wt.% or more, about 0.5 wt.% or more, about 1 wt.% or more, about 2 wt.% or more, about 3 wt.% or more, about 4 wt.% or more, about 5 wt.% or more, about 6 wt.% or more, about 7 wt.% or more, about 8 wt.% or more, or about 9 wt.% or more) of pH adjuster. Each nicotine-containing aggregate can contain about 10 wt.% or less (e.g., about 9 wt.% or less, about 8 wt.% or less, about 7 wt.% or less, about 6 wt.% or less, about 5 wt.% or less, about 4 wt.% or less, about 3 wt.% or less, about 2 wt.% or less, about 1 wt.% or less, about 0.5 wt.% or less, or about 0.1 wt.% or less) of a pH adjuster.

[0048] In at least one exemplary embodiment, the pH adjuster may include ammonium carbonate, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, or any combination thereof.

[0049] In at least one exemplary embodiment, each nicotine-containing aggregate can include an amount of antioxidant ranging from 0 wt.% to about 10 wt.%. For example, each nicotine-containing aggregate can include about 0 wt.% or more (e.g., about 0.1 wt.% or more, about 0.5 wt.% or more, about 1 wt.% or more, about 2 wt.% or more, about 3 wt.% or more, about 4 wt.% or more, about 5 wt.% or more, about 6 wt.% or more, about 7 wt.% or more, about 8 wt.% or more, or about 9 wt.% or more) of antioxidant. Each nicotine-containing aggregate can contain about 10 wt.% or less (e.g., about 9 wt.% or less, about 8 wt.% or less, about 7 wt.% or less, about 6 wt.% or less, about 5 wt.% or less, about 4 wt. or less, about 3 wt.% or less, about 2 wt.% or less, about 1 wt.% or less, about 0.5 wt.% or less, or about 0.1 wt.% or less) of antioxidant.

[0050] In at least one exemplary embodiment, the antioxidant comprises ascorbyl palmitate, tertiary butyl hydroquinone (TBHQ), butyl hydroxytoluene (BHT), ascorbic acid, sodium ascorbate, monosterol citrate, tocopherol, propyl gallate, or any combination thereof.

[0051] FIG. 1 is a flow diagram illustrating a method of forming nicotine-containing aggregates according to at least one exemplary embodiment.

[0052] In some exemplary embodiments, methods of forming such nicotine-containing aggregates generally include heating and cooling a first mixture, adding a nicotine-containing material to the cooled first mixture to form a second mixture, and cooling the second mixture to a further temperature to form one or more solidified structures, such as sheets. The one or more solidified structures can be fragmented to form encapsulated nicotine granules for inclusion in an oral product and can have desired organoleptic properties.

[0053] In at least one exemplary embodiment, a method 100 is provided for preparing nicotine-containing aggregates 162 for inclusion in oral products such as gums, sprays, lozenges, dissolving tablets, non-dissolving chewing gums, films, gels, capsules, and pouches (e.g., including fibers or granules), as shown in Figure 1. The nicotine-containing aggregates 162 may each include a plurality of nicotine particles as described in detail above. The method 100 may be carried out using a batch process, a continuous process, or both batch and continuous processes.

[0054] In at least one exemplary embodiment, the method 100 for preparing the nicotine-containing aggregates 162 includes feeding S120 the solid particulates 122 to a fluid bed granulator. In at least one exemplary embodiment, feeding S120 the solid particulates 122 to the fluid bed granulator includes feeding or adding the solid particulates 122, or a portion of the solid particulates 122, to, for example, a screw feeder of the fluid bed granulator, and then moving (e.g., feeding) the solid particulates 122 from the screw feeder to the fluid bed of the fluid bed granulator using a bulk process or a stepwise process. In at least one exemplary embodiment, feeding S120 the solid particulates 122 to the fluid bed granulator includes adding the solid particulates 122 directly to the fluid bed of the fluid bed granulator using a bulk process or a stepwise process, for example, at the beginning or start of the process 100. In yet another exemplary embodiment, feeding the solid particulate 122 to the fluid bed granulator S120 includes spraying the solid particulate 122, or a portion of the solid particulate 122, onto other materials as described below, such as binder materials, filler materials, and / or other additive materials (such as flavorings, pH adjusters, antioxidants, or any combination thereof).

[0055] In at least one exemplary embodiment, the temperature of the solid particulates 122 may range from about 1° C. to about 100° C. at the time of delivery of S120. For example, the solid particulates 122 may have a solid particulate inlet temperature of about 1° C. or more (e.g., about 5° C. or more, about 10° C. or more, about 20° C. or more, about 30° C. or more, about 40° C. or more, about 50° C. or more, about 60° C. or more, about 70° C. or more, about 80° C. or more, about 90° C. or more, or about 95° C. or more). The solid particulates 122 may have a solid particulate inlet temperature of about 100° C. or less (e.g., about 95° C. or less, about 90° C. or less, about 80° C. or less, about 70° C. or less, about 60° C. or less, about 50° C. or less, about 40° C. or less, about 30° C. or less, about 20° C. or less, about 10° C. or less, or about 5° C. or less). Changing the solid particulate inlet temperature may change the properties of the formed nicotine-containing aggregates 162. For example, in at least one exemplary embodiment, altering the inlet temperature of the solid particulates can affect the stickiness of the solid particulates and thereby how the particles are bonded together during the granulation process.

[0056] The solid particulate 122 comprises a nicotine-containing powder, which comprises a plurality of particulates (or nicotine particles) as described above. The particulates may have an average particle size (90% distribution) ranging from about 0.1 μm to about 3 mm, for example, as described above.

[0057] In some exemplary embodiments, the solid particulate 122 further comprises a filler, as described above. For example, the solid particulate 122 may comprise about 99.99 wt.% or less of a filler (e.g., about 90 wt.% or less, about 85 wt.% or less, about 80 wt.% or less, about 75 wt.% or less, about 70 wt.% or less, about 65 wt.% or less, about 60 wt.% or less, about 55 wt.% or less, about 50 wt.% or less, about 45 wt.% or less, about 40 wt.% or less, about 35 wt.% or less, about 30 wt.% or less, about 25 wt.% or less, about 20 wt.% or less, about 15 wt.% or less, about 10 wt.% or less, or about 5 wt.% or less). Although not shown, in some exemplary embodiments, the method 100 may include contacting a filler with the nicotine-containing powder to form the solid particulate 122.

[0058] In some exemplary embodiments, the solid particulate 122 further comprises an additive, as described above. For example, the solid particulate 122 may and can include an amount of the additive ranging from about 0.1 wt.% to about 40 wt.%. Although not shown, in some exemplary embodiments, the method 100 may include contacting a filler with the nicotine-containing powder to form the solid particulate 122. As described above, in at least one exemplary embodiment, the additive includes a flavoring, a pH adjuster, an antioxidant, or any combination thereof.

[0059] In at least one exemplary embodiment, the method 100 includes pre-processing or pre-treating S110 the solid particulate 122. Pre-processing or pre-treating S110 the solid particulate 122 may include, for example, pre-mixing, pre-wetting, flow improvement, particle size modification, or any combination thereof.

[0060] In at least one exemplary embodiment, pre-processing or pre-treating S110 includes pre-wetting the solid particulate 122. Pre-wetting the solid particulate 122 may include contacting the solid particulate 122 with a (first) binder material such that the solid particulate 122 includes about 40 wt.% or less (e.g., about 35 wt.% or less, about 30 wt.% or less, about 25 wt.% or less, about 20 wt.% or less, about 15 wt.% or less, about 10 wt.% or less, about 5 wt.% or less, about 1 wt.% or less, or about 0.5 wt.% or less) of the binder material.

[0061] In at least one exemplary embodiment, the (first) binder material may be sprayed onto the nicotine-containing powder. The (first) binder material may include a pyrrolidone polymer, a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate, a copolymer of methacrylate and acrylic acid, hydroxypropylmethylcellulose (HPMC), or any combination thereof. Pre-wetting the solid particulates 122 may improve subsequent granulation, for example, by promoting agglomerate formation and / or reducing (or minimizing) ingredient loss.

[0062] In at least one exemplary embodiment, pre-processing or pre-treating S110 includes pre-mixing the solid particulate 122. Pre-mixing the solid particulate 122 may include, for example, mixing the solid particulate 122 using a screw blender, a planetary blender, a V-blender, a ribbon blender, a high shear mixer, or combinations thereof. Pre-mixing the solid particulate 122 can increase the uniformity of the solid particulate 122.

[0063] In at least one exemplary embodiment, pre-processing or pre-treating S110 includes improving the flowability of the solid particulate 122. The flowability of the solid particulate 122 may be improved by subjecting the solid particulate 122 to a roller compaction process (e.g., to increase the density of the solid particulate 122), a spray drying / cooling process (e.g., to form a dry powder), an extrusion mulmelization / spheronization process (e.g., to create solid particulates 122 with a consistent cross-section and / or to form solid particulates 122 with small rounded or spherical granule shapes), other similar industrial processes, or any combination thereof. Increasing the flowability of the solid particulate 122 may help facilitate the granulation process.

[0064] In at least one exemplary embodiment, the method 100 includes providing S130 a binder solution 132 to a fluid bed granulator. For example, the binder solution 132 can be provided in S130 in a manner such that at least a portion of the binder solution 132 contacts at least a portion of the solid particulate 122 so as to fluidize the solid particulate 122.

[0065] Similar to the supply S120 of the solid particulate 122, in at least one exemplary embodiment, the binder solution 132, or a portion of the binder solution 132, may be supplied S130 directly to the fluidized bed of a fluidized bed granulator, e.g., using a bulk process or a step-wise process, at the beginning or start of the process 100 and / or only simultaneously with or after the supply S120 of the solid particulate 122. For example, the binder solution 132 may be sprayed into the fluidized bed of the fluidized bed granulator. The binder solution 132 may be sprayed into the fluidized bed. For example, in some exemplary embodiments, the binder solution 132 may be sprayed onto the solid particulate 122 that is within the fluidized bed. In at least one exemplary embodiment, the binder solution 132 may be sprayed in a downward manner, e.g., from a top spray position, in an upward manner, e.g., from a bottom spray position, in a sideways manner, e.g., from a side spray position, or any combination thereof. Varying the spray location as well as the spray pattern and spray rate may only change the properties of the formed nicotine-containing aggregates 162, such as particle size and density of the nicotine-containing aggregates 162. For example, in at least one exemplary embodiment, increasing air flow may favor smaller particle size. In at least one exemplary embodiment, increasing temperature may shorten processing time.

[0066] In at least one exemplary embodiment, the temperature of the binder solution 132 during the supply S130 of the binder solution 132 to the fluid bed granulator ranges from about 1° C. to about 99° C. For example, the binder solution may have a binder inlet temperature of about 1° C. or higher (e.g., about 5° C. or higher, about 10° C. or higher, about 20° C. or higher, about 30° C. or higher, about 40° C. or higher, about 50° C. or higher, about 60° C. or higher, about 70° C. or higher, about 80° C. or higher, about 85° C. or higher, about 90° C. or higher, or about 95° C. or higher). The binder solution may have a binder inlet temperature of about 99° C. or lower (e.g., about 95° C. or lower, about 90° C. or lower, about 85° C. or lower, about 80° C. or lower, about 70° C. or lower, about 60° C. or lower, about 50° C. or lower, about 40° C. or lower, about 30° C. or lower, about 20° C. or lower, about 10° C. or lower, or about 5° C. or lower). Varying the binder inlet temperature can change the properties of the binder solution 132, such as viscosity and flowability, and can also affect the spray pattern and the properties of the nicotine-containing aggregates 162 formed.

[0067] In at least one exemplary embodiment, the binder solution 132 includes a (second) binder material and a solvent. In at least one exemplary embodiment, the (second) binder solution 132 may include an amount of the (second) binder material ranging from about 0.05 wt.% to about 50 wt.%, and an amount of the solvent ranging from about 60 wt.% to about 99.95 wt.%. For example, the (second) binder solution 132 can include about 0.05 wt.% or more of the (second) binder material (e.g., about 0.1 wt.% or more, about 0.5 wt.% or more, about 1 wt.% or more, about 5 wt.% or more, about 10 wt.% or more, about 15 wt.% or more, about 20 wt.% or more, about 25 wt.% or more, about 30 wt.% or more, about 35 wt.% or more, about 40 wt.% or more, or about 50 wt.% or more). The (second) binder solution 132 may contain about 50 wt.% or less of the (second) binder material (e.g., about 45 wt.% or less, about 40 wt.% or less, about 35 wt.% or less, about 30 wt.% or less, about 25 wt.% or less, about 20 wt. or less, about 15 wt.% or less, about 10 wt.% or less, about 5 wt.% or less, about 1 wt.% or less, about 0.5 wt.% or less, or about 0.1 wt.% or less). The (second) binder solution 132 may include about 60 wt.% or more of solvent (e.g., about 65 wt.% or more, about 70 wt.% or more, about 75 wt.% or more, about 80 wt.% or more, about 85 wt.% or more, about 90 wt.% or more, about 95 wt.% or more, or about 97 wt.% or more). The (second) binder solution 132 may include about 99.95 wt.% or less of solvent (e.g., about 99 wt.% or less, about 97 wt.% or less, about 95 wt.% or less, about 90 wt.% or less, about 85 wt.% or less, about 80 wt.% or less, about 75 wt.% or less, about 70 wt.% or less, or about 65 wt.% or less).

[0068] In at least one exemplary embodiment, the binder solution 132, including the (second) binder material and the solvent, can be a homogenous liquid mixture. Although not shown, in some exemplary embodiments, the method 100 can include homogenizing the binder solution 132.

[0069] In at least one exemplary embodiment, the (second) binder material may include a pyrrolidone polymer, a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate, a copolymer of methacrylate and acrylic acid, hydroxypropylmethylcellulose (HPMC), or any combination thereof. In at least one exemplary embodiment, the solvent may include water. In other embodiments, the solvent may include water, ethanol, methanol, propanol, hexane, or any combination thereof.

[0070] In some exemplary embodiments, the method 100 includes providing S140 a filler material 142 to the fluid bed granulator. For example, the filler material 142 may be provided in S140 in a manner such that at least a portion of the filler material 142 contacts at least a portion of the solid particulate 112 and / or the binder solution 132. In at least one exemplary embodiment, the solid particulate 122 includes a first filler material and a second filler material 142 may be added to the fluid bed granulator.

[0071] Similar to providing S120 the solid particulates 122 and / or providing S130 the binder solution 132, in some exemplary embodiments, the filler 142, or a portion of the filler 142, may be provided directly S140 to the fluidized bed of a fluidized bed granulator, e.g., using a bulk process or a stepwise process, simultaneously with or only subsequent to providing S120 the solid particulates 122 and / or providing S130 the binder solution 132. In at least one exemplary embodiment, providing S140 the filler 142 to the fluidized bed granulator includes providing or adding the filler 142, or a portion of the filler 142, to, e.g., a screw feeder of the fluidized bed granulator, and then moving (e.g., feeding) the filler from the screw feeder to the fluidized bed of the fluidized bed granulator, e.g., using a bulk process or a stepwise process. The filler 142 may include a polysaccharide, a bulk sweetener, a sugar alcohol, or any combination thereof, as described above.

[0072] In at least one exemplary embodiment, the temperature of the filler 142 at the time of feeding S140 the filler 142 to the fluid bed granulator ranges from about 1° C. to about 99° C. For example, the filler 142 may have an inlet temperature of about 1° C. or more (e.g., about 5° C. or more, about 10° C. or more, about 20° C. or more, about 30° C. or more, about 40° C. or more, about 50° C. or more, about 60° C. or more, about 70° C. or more, about 80° C. or more, about 85° C. or more, about 90° C. or more, or about 95° C. or more). The filler 142 may have an inlet temperature of about 99° C. or less (e.g., about 95° C. or less, about 90° C. or less, about 85° C. or less, about 80° C. or less, about 70° C. or less, about 60° C. or less, about 50° C. or less, about 40° C. or less, about 30° C. or less, about 20° C. or less, about 10° C. or less, or about 5° C. or less).

[0073] In at least one exemplary embodiment, the method 100 includes providing S150 an additive 152 to a fluid bed granulator. For example, the additive 152 may be provided S150 in such a manner that at least a portion of the additive 152 contacts at least a portion of the solid particulate 112 and / or at least a portion of the binder solution 132. In at least one exemplary embodiment, the solid particulate 122 including the first additive and the second additive 152 may be added to the fluid bed granulator. Similar to providing S120 the solid particulate 122 and / or providing S130 the binder solution 132, in some exemplary embodiments, a portion of the additive 152 may be provided S150 directly to the fluid bed of the fluid bed granulator using a bulk process or a step-wise process, for example, simultaneously with or only after providing S120 the solid particulate 122 and / or providing S130 the binder solution 132 and / or providing S140 the filler material 142.

[0074] In at least one exemplary embodiment, the temperature of additive 152 at feeding additive 152 to the fluid bed granulator S150 ranges from about 1° C. to about 99° C. For example, additive 152 can have an inlet temperature of about 1° C. or more (e.g., about 5° C. or more, about 10° C. or more, about 20° C. or more, about 30° C. or more, about 40° C. or more, about 50° C. or more, about 60° C. or more, about 70° C. or more, about 80° C. or more, about 85° C. or more, about 90° C. or more, or about 95° C. or more). Additive 152 can have an inlet temperature of about 99° C. or less (e.g., about 95° C. or less, about 90° C. or less, about 85° C. or less, about 80° C. or less, about 70° C. or less, about 60° C. or less, about 50° C. or less, about 40° C. or less, about 30° C. or less, about 20° C. or less, about 10° C. or less, or about 5° C. or less).

[0075] In at least one exemplary embodiment, the additive 152 includes a flavoring, a pH adjuster, an antioxidant, or any combination thereof, as described above. The provision of the additive 152 may include simultaneous or subsequent addition of the flavoring, pH adjuster, antioxidant, or combination thereof. Although not shown, in some exemplary embodiments, the method 100 may include mixing the flavoring and / or the pH adjuster and / or the antioxidant to form the additive 152.

[0076] Although not specifically shown, one skilled in the art will recognize that the feeding S120 of the solid particulate 122, the feeding S130 of the binder solution 132, the feeding S140 of the filler 142, and / or the feeding S150 of the additives 152 to the fluid bed granulator can occur simultaneously or sequentially, and that a single portion or portions of the solid particulate 122, a single portion or portions of the binder solution 132, a single portion or portions of the filler 142, and / or a single portion or portions of the additives 152 can be added simultaneously or sequentially. For example, in at least some exemplary embodiments, a first portion of the solid particulate 122 can be added to the fluid bed granulator, and then a second portion of the solid particulate 122 can be added to the fluid bed granulator (e.g., using a spraying process). The provision of, and the relationship between, the solid particulates 122, binder solution 132, filler material 142, and / or additives 152 may be selected to prepare a nicotine-containing aggregate 162 having desired physical and organoleptic properties.

[0077] In at least one exemplary embodiment, the method 100 includes circulating S160 a fluidized bed including solid particulates 122, binder solution 132, filler material 142, and / or additives 152 to form a nicotine-containing aggregate 162. In at least one exemplary embodiment, the flow rate of the circulation S160 may be adjusted to vary the concentration of the nicotine-containing aggregate 162. In at least one exemplary embodiment, the duration of the circulation S160 may be adjusted to vary the moisture content of the nicotine-containing aggregate 162.

[0078] The nicotine-containing aggregates as described above are suitable for inclusion in oral products such as gums, sprays, lozenges, dissolving tablets, non-dissolving chewing gums, films, gels, capsules, and pouches (e.g., containing fibers or granules).

[0079] In at least one exemplary embodiment, the oral product is an oral tobacco product, an oral non-tobacco product, an oral cannabis product, or any combination thereof. The oral product may be in the form of a loose material (e.g., a loose cellulosic material), a shaped material (e.g., a plug or twist), a bagged material, a tablet, a lozenge, a chewing gum, a gum, a film, other oral products, or any combination thereof.

[0080] In at least one exemplary embodiment, the oral product may include chewing tobacco, snus, moist snuff, dry snuff, other smokeless tobacco, non-tobacco products for oral consumption, or any combination thereof.

[0081] Although several exemplary embodiments have been disclosed herein, it should be understood that other variations are possible. Such variations are not to be regarded as departing from the spirit and scope of the present disclosure, and all such modifications that would be obvious to one skilled in the art are intended to be included within the scope of the following claims.

[0082] Although described with reference to specific examples and drawings, modifications, additions, and substitutions of the exemplary embodiments may be made in various ways as described by those skilled in the art. For example, the techniques described may be performed in different orders than as described, and / or elements of the systems, architectures, devices, circuits, etc. described may be connected or combined in different ways than as described above, or the results may be achieved by other elements or equivalents as appropriate.

Claims

1. 1. A method for preparing a nicotine-containing aggregate, comprising: providing solid particulates to a fluid bed granulator, the solid particulates comprising a nicotine-containing powder; supplying a binder solution to the fluid bed granulator such that the binder solution contacts the solid particulates; circulating the solid fine particles inside the fluidized bed granulator, The binder solution is supplied into the fluidized bed granulator while the solid fine particles are circulating; Supplying the solid particulates to the fluidized bed granulator comprises adding a first portion of the solid particulates to the fluidized bed granulator, and adding a second portion of the solid particulates to the fluidized bed granulator during circulation of the first portion of the solid particulates and during supply of the binder solution. method.

2. 10. The method of claim 1 , The binder solution and the solid particles are simultaneously fed into the fluidized bed granulator. method.

3. 10. The method of claim 1 , The binder solution includes a binder material, The binder material comprises a pyrrolidone polymer, a copolymer of polyvinylpyrrolidone (PVP) and vinyl acetate, a copolymer of methacrylate and acrylic acid, hydroxypropyl methylcellulose (HPMC), or any combination thereof; method.

4. 10. The method of claim 1 , The binder solution includes a binder material and a solvent; The solvent comprises water. method.

5. 10. The method of claim 1 , The binder solution is dispensed downward from an upper spray location, upward from a lower spray location, sideways from a sideways spray location, or any combination thereof; method.

6. 10. The method of claim 1 , the second portion of the solid particulates is sprayed onto other materials inside the fluid bed granulator; method.

7. 10. The method of claim 1 , the binder solution has a binder inlet temperature in the range of 1° C. to 99° C.; The solid particulate has a solid particulate inlet temperature in the range of 1° C. to 100° C. method.

8. 10. The method of claim 1 , The nicotine-containing powder comprises a plurality of microparticles having an average diameter ranging from 0.1 μm to 3 mm. method.

9. 10. The method of claim 1 , The method further comprises subjecting the solid fine particles to a pretreatment before supplying the solid fine particles. method.

10. 。 10. The method of claim 9, The pre-treatment step includes spraying the nicotine-containing powder with a binder material to pre-wet the solid particles. method.

11. 。 10. The method of claim 1 , The solid particulate further comprises a filler. method.

12. 12. The method of claim 11, further comprising contacting the filler material with the nicotine-containing powder. method.

13. 12. The method of claim 11, The filler comprises a polysaccharide, a bulk sweetener, a sugar alcohol, or any combination thereof; method.

14. 10. The method of claim 1 , adding a filler to the fluid bed granulator, wherein the filler contacts the solid particulates. method.

15. 15. The method of claim 14, The supplying of the solid particulates to the fluidized bed granulator includes spraying the solid particulates onto the filler. method.

16. 10. The method of claim 1 , The solid particulate further comprises a fragrance, a pH adjuster, an antioxidant, or any combination thereof; method.

17. 10. The method of claim 1 , adding an additive to the fluid bed granulator such that the additive contacts the solid particulates; The additives include a fragrance, a pH adjuster, an antioxidant, or any combination thereof. method.